[New treatments present new challenges : Ocular side effects of belantamab mafodotin] [0.03%]
[新的治疗带来新的挑战：Belantamab mafodotin的眼部副作用]
Peter Werkl,Nora Woltsche,Barbara Silbernagel et al.
Peter Werkl et al.
Sophia Weiß,Veit Rohde,Xenia Hautmann et al.
Sophia Weiß et al.
[DMEK after incomplete tectonic penetrating keratoplasty-the "patchwork" keratoplasty] [0.03%]
[角膜移植术不全时的DMEK手术-"百衲细纱"式角膜移植术]
Felix Hagenau,Maximilian J Gerhardt,Wolfgang J Mayer et al.
Felix Hagenau et al.
[Pleasing development of a central arterial occlusion after conservative treatment] [0.03%]
[中央动脉闭塞保守治疗后的良好转归]
Jaro Stühmer-Beckh,Maged Alnawaiseh,Alina Blumberg et al.
Jaro Stühmer-Beckh et al.
[Stress and other risk factors in central serous chorioretinopathy-A myth?] [0.03%]
中心性浆液性脉络膜视网膜病变中的压力及其他危险因素-一种神话吗?
Since the initial description of central serous chorioretinopathy (CSC) by von Graefe in 1866, various risk factors for this condition have been described and discussed. In addition to established factors, such as the use of corticosteroids...
[Screening recommendations for glaucoma, age-related macular degeneration and diabetic eye diseases] [0.03%]
眼病筛査的专家共识（原发性开角型青光眼、年龄相关性黄斑变性和糖尿病视网膜病变）
Background: The main causes of blindness, age-related macular degeneration (AMD), glaucoma and diabetic eye diseases (DED), are becoming increasingly more important in terms of health economics due to the demographic deve...